Vermont is poised to become the first state requiring drug companies to explain their price increases, and Bob and Deborah Messing think that’s a good idea. The Messings live in Montpelier and are in their early 70s. She’s on Orencia, …
Spending on medicines increased by double digits for a second year in 2015 and reached $425 billion based on invoice prices. After adjusting for rebates and other price concessions by manufacturers, net spending was $310 billion, up 8.5 percent over …
U.S. prices for the world’s 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters. The finding underscores a transatlantic gulf between the price of treatments for a range of …
